Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Shared PRAME epitopes are T-cell targets in NUT carcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 10, 2026
Computational design of orthogonal TCR α/β interfaces for dual-TCR therapeutics.
Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026
Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Journal: Therapeutic advances in medical oncology
Published: September 08, 2025
Shared PRAME Epitopes are T-Cell Targets in NUT Carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma.
Journal: The oncologist
Published: August 06, 2023
Showing 1-5 of 5
Last Updated: 09/26/2026